Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|November 14, 2019
Antibodies against HPV16E6 oncoprotein in the Swiss HIV cohort study: Kinetics and anal cancer risk predictionJean-Damien Combes, Gary M Clifford, Huldrych F Günthard, et al.
Familial Cancer|April 29, 2023
Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literatureKetty Hu-Heimgartner, Noémie Lang, Aurélie Ayme, et al.
Breast Cancer Research and Treatment|January 13, 2019
BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patientsAlex Friedlaender, Aurélie Vuilleumier, Valeria Viassolo, et al.
Virology|March 26, 2017
Isolation and characterization of a novel putative human polyomavirusTarik Gheit, Sankhadeep Dutta, Javier Oliver, et al.
The Journal of Infectious Diseases|November 23, 2019
Incidence and Clearance of Anal Human Papillomavirus (HPV)-16 and HPV-18 Infection, and Their Determinants, Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in FranceCatharina J Alberts, Isabelle Heard, Ana Canestri, et al.
The Journal of Infectious Diseases|July 25, 2024
Cumulative Detection of Anal High-Grade Squamous Intraepithelial Lesions Over 2-Year Follow-up in Men Who Have Sex With Men Living With Human Immunodeficiency Virus in FranceJean-Damien Combes, Jean-Michel Didelot, Sylvie Radenne, et al.
Cancer Research|June 24, 2011
Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancerSana Intidhar Labidi-Galy, Vanja Sisirak, Pierre Meeus, et al.
Open Forum Infectious Diseases|April 16, 2024
Epstein-Barr Virus DNA Is Associated With Conjunctival Squamous Cell Carcinomas: A Case-Control Study From ZimbabweRacheal S Dube Mandishora, Luisa Galati, Richard R Reich, et al.
Oral Oncology|April 27, 2021
History of tonsillectomy and risk of oropharyngeal cancerJean-Damien Combes, Nicolas Voisin, Sophie Périé, et al.
Gynecologic Oncology|October 13, 2019
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancersS Intidhar Labidi-Galy, Thibault de La Motte Rouge, Olfa Derbel, et al.
Pageof 5